Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride

PHASE3CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Vildagliptin

DRUG

Placebo

Trial Locations (55)

Unknown

Novartis Investigative Site, Box Hill

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Parkville

Novartis Investigative Site, St Leonards

Novartis Investigative Site, Anderbeck

Novartis Investigative Site #1, Berlin

Novartis Investigative Site #2, Berlin

Novartis Investigative Site #3, Berlin

Novartis Investigative Site #4, Berlin

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Hildesheim

Novartis Investigative Site, Sangerhausen

Novartis Investigative Site, Budapest

Novartis Investigative Site, Érd

Novartis Investigative Site, Törökbálint

Novartis Investigative Site, Bergamo

Novartis Investigative Site, Cosenza

Novartis Investigative Site, Milan

Novartis Investigative Site, Padua

Novartis Investigative Site, Pisa

Novartis Investigative Site #1, Roma

Novartis Investigative Site #2, Roma

Novartis Investigative Site, Torino

Novartis Investigative Site #1, Aguascalientes

Novartis Investigative Site #2, Aguascalientes

Novartis Investigative Site #3, Aguascalientes

Novartis Investigative Site #1, Durango

Novartis Investigative Site #2, Durango

Novartis Investigative Site #3, Durango

Novartis Investigative Site #1, Guadalajara

Novartis Investigative Site #2, Guadalajara

Novartis Investigative Site #3, Guadalajara

Novartis Investigative Site #4, Guadalajara

Novartis Investigative Site #5, Guadalajara

Novartis Investigative Site, México

Novartis Investigative Site #1, Pachuca

Novartis Investigative Site #2, Pachuca

Novartis Investigative Site #3, Pachuca

Novartis Investigative Site, Manila

Novartis Investigative Site #1, Quezon City

Novartis Investigative Site #2, Quezon City

Novartis Investigative Site, Alba Iulia

Novartis Investigative Site, Bucharest

Novartis Investigative Site #1, Oradea

Novartis Investigative Site #2, Oradea

Novartis Investigative Site, Târgu Mureş

Novartis Investigative Site, Bundang

Novartis Investigative Site #1, Seoul

Novartis Investigative Site #2, Seoul

Novartis Investigative Site #3, Seoul

Novartis Investigative Site, Suwon

Novartis Investigative Site, Changhua

Novartis Investigative Site, Taichung

Novartis Investigative Site, Taipei

Novartis Investigative Site, Yongkang District

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01233622 - Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride | Biotech Hunter | Biotech Hunter